Oracle
ORCL NYSE Application Software Financials FY2017βFY2026
Oracle's revenue rose 17.4% to $67.4 billion in fiscal 2026. Its operating margin was 30.6%, down from 30.8% a year earlier. Free cash flow was β$23.7 billion. It paid out $5.9 billion in dividends and buybacks. The diluted share count rose 1.7%.
What Oracle does
Oracle sells software, cloud computing services and hardware that businesses, governments and schools use to run their operations. Its best-known products are its database software and Java, along with business applications for finance, human resources, supply chains and sales, plus NetSuite for smaller companies and Oracle Health for hospitals and doctors. Customers can rent these as cloud services, run them in their own data centers, or mix the two.
Oracle reports three businesses: cloud and software, hardware, and services. Cloud and software is the largest. It covers cloud subscriptions, software licenses and the support contracts that nearly all license buyers add. Cloud revenue made up 51% of Oracle's total revenue in fiscal 2026, and its cloud infrastructure arm, which rents out computing power, storage and networking, including for training AI models, brought in 53% of cloud revenue. Oracle names Adobe, Alphabet, Amazon, Cisco, IBM, Intel, Microsoft, Salesforce, SAP and Workday among its competitors.
Oracle spent $10.3 billion on research and development in fiscal 2026. It sells directly through its own sales force and through partners. At the end of May 2026 it had about 141,000 full-time employees, roughly 49,000 of them in the United States.
- Legal name
- Oracle Corporation
- Fiscal year ends
- May 31, 2026
- Latest annual report
- 10-K Β· Jun 22, 2026
- Accession Β· CIK
- 0001193125-26-277521
0001341439
Revenue and margins
Oracle had $67.4B of revenue in fiscal 2026, up 17.4% on the year before.
Net income and earnings per share
From fiscal 2017 to 2026, diluted EPS grew 11.2% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β$23.7B in fiscal 2026, β35.2% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Oracle returned $5.9B to shareholders in fiscal 2026. The diluted share count rose 1.7%.
Value Oracle yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$105.3B and divides by 2,914.0M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 19.8x Β· peers 21.8x Β· sector 33.5x.
Balance sheet
Cash, debt and the ratios that show how comfortably Oracle can carry it.
| Fiscal year end | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash and short-term investments | $21.9B | $10.2B | $10.7B | $11.2B | $31.9B |
| Debt incl. finance leases | $0.0M | $90.5B | $86.9B | $95.5B | $137.2B |
| Net debt / EBITDA | β1.6x | 4.2x | 3.6x | 3.5x | 3.5x |
| Debt / equity | β | β | 10.0x | 4.7x | 3.2x |
| Interest coverage | 4.0x | 3.7x | 4.4x | 4.9x | 4.5x |
| Current ratio | 1.6x | 0.9x | 0.7x | 0.8x | 1.1x |
| Quick ratio | 1.6x | 0.9x | 0.7x | 0.7x | 1.1x |
| Total assets | $109.3B | $134.4B | $141.0B | $168.4B | $261.8B |
| Total liabilities | $115.1B | $132.8B | $131.7B | $147.4B | $218.7B |
| Shareholders' equity | β$6.2B | $1.1B | $8.7B | $20.5B | $42.5B |
| Net debt (β = net cash) | β$21.9B | $80.3B | $76.2B | $84.3B | $105.3B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$3.5M
1 insider
Sold, 12 months
$99.3M
9 insiders
Of sales under plans
79%
$78.1M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 29, 2026 | Stephen H RusckowskiDirector | Bought | 25,000 | $139.35 | $3.5M | Form 4 |
| Sep 22, 2026 | Maria SmithEVP, Chief Accounting Officer | Sold | 2,631 | $151.70 | $0.4M | Form 4 |
| Sep 22, 2026 | Michael D. SiciliaChief Executive Officer | Sold plan | 22,562 | $151.59 | $3.4M | Form 4 |
| Sep 16, 2026 | Michael D. SiciliaChief Executive Officer | Sold plan | 10,882 | $139.94 | $1.5M | Form 4 |
| Jun 24, 2026 | Jeffrey HenleyVice Chairman, Director | Sold plan | 400,000 | $159.16 | $63.7M | Form 4 |
| Apr 16, 2026 | Stuart LeveyEVP, Chief Legal Officer | Sold plan | 15,000 | $176.19 | $2.6M | Form 4 |
| Feb 9, 2026 | Clayton M. MagouyrkChief Executive Officer | Sold | 10,000 | $155.23 | $1.6M | Form 4 |
| Jan 15, 2026 | Douglas A KehringEVP, Principal Financial Offcr | Sold plan | 35,000 | $194.89 | $6.8M | Form 4 |
| Dec 24, 2025 | Mark HuraPres., Global Field Operations | Sold | 15,000 | $196.89 | $3.0M | Form 4 |
| Dec 23, 2025 | Naomi O SeligmanDirector | Sold | 2,223 | $196.61 | $0.4M | Form 4 |
| Dec 19, 2025 | Clayton M. MagouyrkChief Executive Officer | Sold | 10,000 | $192.52 | $1.9M | Form 4 |
| Oct 28, 2025 | Jeffrey BergDirector | Sold | 49,365 | $283.02 | $14.0M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY24 | FY25 | FY26 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 5 / 8 | 7 / 8 | 5 / 8 |
| Accruals ratio | β6.0% | β5.4% | β6.9% |
| Altman Z'' | β0.14 | 0.24 | 0.80 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Oracle ORCL | $378.5B | 17.4% | 30.6% | β35.2% | 14.2% | 19.8x | 5 | |
| Salesforce CRM | $204.1B | 9.6% | 20.1% | 34.7% | 10.8% | 22.7x | 7 | Compare β |
| Adobe ADBE | $104.3B | 10.5% | 36.6% | 41.5% | 65.9% | 14.7x | 7 | Compare β |
| Intuit INTU | $95.1B | 13.9% | 27.4% | 40.4% | 22.0% | β | 6 | Compare β |
| Workday WDAY | $51.7B | 13.1% | 7.6% | 29.1% | 10.6% | 42.5x | 7 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $37.8B | $39.4B | $39.5B | $39.1B | $40.5B | $42.4B | $50.0B | $53.0B | $57.4B | $67.4B |
| Gross profit | $23.0B | $24.3B | β | β | β | β | β | β | β | β |
| Research and development | $6.2B | $6.1B | $6.0B | $6.1B | $6.5B | $7.2B | $8.6B | $8.9B | $9.9B | $10.3B |
| Operating income | $12.9B | $13.3B | $13.5B | $13.9B | $15.2B | $10.9B | $13.1B | $15.4B | $17.7B | $20.6B |
| Interest expense | $1.8B | $2.0B | $2.1B | $2.0B | $2.5B | $2.8B | $3.5B | $3.5B | $3.6B | $4.6B |
| Pretax income | $11.5B | $12.9B | $12.3B | $12.1B | $13.0B | $7.6B | $9.1B | $11.7B | $14.2B | $19.6B |
| Income tax | $2.2B | $8.8B | $1.2B | $1.9B | β$747M | $932M | $623M | $1.3B | $1.7B | $2.5B |
| Net income | $9.5B | $3.6B | $11.1B | $10.1B | $13.7B | $6.7B | $8.5B | $10.5B | $12.4B | $17.1B |
| Diluted EPS | $2.24 | $0.85 | $2.97 | $3.08 | $4.55 | $2.41 | $3.07 | $3.71 | $4.34 | $5.83 |
| Diluted shares | 4.22B | 4.24B | 3.73B | 3.29B | 3.02B | 2.79B | 2.77B | 2.82B | 2.87B | 2.91B |
| Cash flow | ||||||||||
| Cash from operations | $14.1B | $15.4B | $14.6B | $13.1B | $15.9B | $9.5B | $17.2B | $18.7B | $20.8B | $32.0B |
| Capital expenditure | $2.0B | $1.7B | $1.7B | $1.6B | $2.1B | $4.5B | $8.7B | $6.9B | $21.2B | $55.7B |
| Free cash flow | $12.1B | $13.7B | $12.9B | $11.6B | $13.8B | $5.0B | $8.5B | $11.8B | β$394M | β$23.7B |
| Depreciation and amortization | $2.5B | $2.8B | $2.9B | $3.0B | $2.9B | $3.1B | $6.1B | $6.1B | $6.2B | $9.3B |
| Stock-based compensation | $1.4B | $1.6B | $1.7B | $1.6B | $1.8B | $2.6B | $3.5B | $4.0B | $4.7B | $4.8B |
| Acquisitions | $11.2B | $1.7B | $363M | $124M | $41.0M | $148M | $27.7B | $63.0M | $0.0M | $0.0M |
| Share buybacks | $3.6B | $11.3B | $36.1B | $19.2B | $20.9B | $16.2B | $1.3B | $1.2B | $600M | $95.0M |
| Dividends paid | $2.6B | $3.1B | $2.9B | $3.1B | $3.1B | $3.5B | $3.7B | $4.4B | $4.7B | $5.8B |
| Dividends and buybacks | $6.2B | $14.5B | $39.1B | $22.3B | $24.0B | $19.7B | $5.0B | $5.6B | $5.3B | $5.9B |
| Balance sheet | ||||||||||
| Cash and short-term investments | $21.8B | $67.3B | $37.8B | $43.1B | $46.6B | $21.9B | $10.2B | $10.7B | $11.2B | $31.9B |
| Total debt | $48.1B | $56.1B | $56.2B | $71.6B | $84.2B | $0.0M | $90.5B | $86.9B | $92.6B | $129.5B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $2.9B | $7.7B |
| Current assets | $74.5B | $76.2B | $46.4B | $52.1B | $55.6B | $31.6B | $21.0B | $22.6B | $24.6B | $46.6B |
| Current liabilities | $24.2B | $19.1B | $18.6B | $17.2B | $24.2B | $19.5B | $23.1B | $31.5B | $32.6B | $41.8B |
| Inventory | $300M | $398M | $320M | $211M | $142M | $314M | $298M | $334M | $303M | $0.0M |
| Property and equipment, net | $5.3B | $5.9B | $6.3B | $6.2B | $7.0B | $9.7B | $17.1B | $21.5B | $43.5B | $100.0B |
| Total assets | $135.0B | $137.9B | $108.7B | $115.4B | $131.1B | $109.3B | $134.4B | $141.0B | $168.4B | $261.8B |
| Total liabilities | $79.9B | $91.0B | $86.3B | $102.7B | $125.2B | $115.1B | $132.8B | $131.7B | $147.4B | $218.7B |
| Shareholders' equity | $53.9B | $46.4B | $21.8B | $12.1B | $5.2B | β$6.2B | $1.1B | $8.7B | $20.5B | $42.5B |
| Margins | ||||||||||
| Gross margin | 60.9% | 61.7% | β | β | β | β | β | β | β | β |
| Operating margin | 34.2% | 33.7% | 34.3% | 35.6% | 37.6% | 25.7% | 26.2% | 29.0% | 30.8% | 30.6% |
| EBITDA margin | 40.7% | 40.8% | 41.7% | 43.2% | 44.8% | 33.1% | 38.4% | 40.6% | 41.6% | 44.4% |
| Net margin | 25.0% | 9.1% | 28.1% | 25.9% | 34.0% | 15.8% | 17.0% | 19.8% | 21.7% | 25.4% |
| FCF margin | 32.0% | 34.7% | 32.6% | 29.6% | 34.0% | 11.9% | 17.0% | 22.3% | β0.7% | β35.2% |
| Returns | ||||||||||
| Return on capital | 14.0% | 11.3% | 32.0% | 28.5% | 35.8% | β | 45.0% | 16.4% | 16.3% | 14.2% |
| Return on capital employed | 12.6% | 11.6% | 13.0% | 14.8% | 14.8% | 11.1% | 13.0% | 13.9% | 14.4% | 11.6% |
| Return on equity | 18.7% | 7.2% | 32.5% | 59.9% | 158.8% | β | β | β | 85.4% | 54.3% |
| Return on assets | 7.7% | 2.6% | 9.0% | 9.0% | 11.2% | 5.6% | 7.0% | 7.6% | 8.0% | 8.0% |
| Growth | ||||||||||
| Revenue growth | 2.0% | 4.2% | 0.3% | β1.1% | 3.6% | 4.8% | 17.7% | 6.0% | 8.4% | 17.4% |
| Net income growth | 6.2% | β62.1% | 209.0% | β8.6% | 35.6% | β51.1% | 26.6% | 23.1% | 18.9% | 37.3% |
| EPS growth | 8.2% | β62.1% | 249.4% | 3.7% | 47.7% | β47.0% | 27.4% | 20.9% | 17.0% | 34.3% |
| FCF growth | β3.1% | 12.8% | β5.6% | β10.2% | 18.8% | β63.4% | 68.5% | 39.4% | β103.3% | β |
| Share count change | β2.0% | 0.5% | β11.9% | β11.7% | β8.3% | β7.8% | β0.7% | 2.1% | 1.5% | 1.7% |
| Financial health | ||||||||||
| Net debt / EBITDA | 1.7x | β0.7x | 1.1x | 1.7x | 2.1x | β1.6x | 4.2x | 3.6x | 3.5x | 3.5x |
| Debt / equity | 0.9x | 1.2x | 2.6x | 5.9x | β | β | β | 10.0x | 4.7x | 3.2x |
| Interest coverage | 7.2x | 6.6x | 6.5x | 7.0x | 6.1x | 4.0x | 3.7x | 4.4x | 4.9x | 4.5x |
| Current ratio | 3.1x | 4.0x | 2.5x | 3.0x | 2.3x | 1.6x | 0.9x | 0.7x | 0.8x | 1.1x |
| Quick ratio | 3.1x | 4.0x | 2.5x | 3.0x | 2.3x | 1.6x | 0.9x | 0.7x | 0.7x | 1.1x |
| Capital allocation | ||||||||||
| Capex / revenue | 5.4% | 4.4% | 4.2% | 4.0% | 5.3% | 10.6% | 17.4% | 13.0% | 37.0% | 82.6% |
| Stock comp / revenue | 3.6% | 4.1% | 4.2% | 4.1% | 4.5% | 6.2% | 7.1% | 7.5% | 8.1% | 7.1% |
| Payouts / FCF | 51.2% | 106.1% | 303.1% | 192.7% | 174.5% | 391.9% | 58.7% | 47.4% | β | β |
| Quality scores | ||||||||||
| Piotroski F-score | 7.0 | 5.0 | 5.0 | 7.0 | 5.0 | 5.0 | 6.0 | 5.0 | 7.0 | 5.0 |
| Altman Z'' | 4.5 | 4.4 | 2.7 | 2.6 | 1.9 | 0.4 | β0.1 | β0.1 | 0.2 | 0.8 |
| Accruals ratio | β3.8% | β8.7% | β2.8% | β2.7% | β1.7% | β2.4% | β7.1% | β6.0% | β5.4% | β6.9% |
Source: SEC EDGAR XBRL filings (CIK 0001341439). Data updated October 9, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.